Therapeutic application of matrix biology.
Tschopp
J F
JF
Telios Pharmaceuticals, Inc., San Diego, California 92121, USA.
Craig
W S
WS
Tolley
J
J
Blevitt
J
J
Mazur
C
C
Pierschbacher
M D
MD
D000595:Amino Acid Sequence; D023181:Antimicrobial Cationic Peptides; D001672:Biocompatible Materials; D002448:Cell Adhesion; D005109:Extracellular Matrix / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000737:chemistry; D010455:Peptides / Q000737:chemistry; D010456:Peptides, Cyclic / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D019736:Prostheses and Implants; D014407:Tumor Cells, Cultured
D023181:Antimicrobial Cationic Peptides; D001672:Biocompatible Materials; D009842:Oligopeptides; D010455:Peptides; D010456:Peptides, Cyclic; C076536:Peptite 2000; C047981:arginyl-glycyl-aspartic acid; C085362:TP 9201; D005340:Fibrinogen